KaliVir Immunotherapeutics
Develops oncolytic immunotherapies for patients with advanced solid tumors
$14MSeries A
Role not disclosedActivity from announced rounds
Develops oncolytic immunotherapies for patients with advanced solid tumors
Builds AI agents for institutional investors to surface market-moving signals in public markets
Develops deployment-ready robotic intelligence and automation solutions for manufacturing